Description

This issue of Vital Signs, released on November 27, 2006, provides a Q&A session with Gerry Purdy, VP and Chief Analyst, Information and Communication Technologies, on the use of wireless communications in the pharmaceutical sector. Additionally, an emerging company profile is provided for MannKind Corporation, a leader in pulmonary insulin product development. Reimbursement and regulatory news from the FDA and CMS is also provided for the week of November 13 - November 17, 2006.